CHAI announces an agreement with the American Cancer Society, Pfizer Inc., and Cipla Inc. to expand access to 16 essential cancer treatment medications, including chemotherapies, in Kenya, Tanzania, Ethiopia, Uganda, Nigeria, and Rwanda, where 44 percent of cancer cases in sub-Saharan Africa occur.